Malay Language Translation, Cultural Adaptation and Pilot Testing of the SARC-F Questionnaire for Screening Sarcopenia Among the Malaysian Population

Main Article Content

Muhammad Akmal Hakimi Mohd Aris
Mohamad Sayyidil Irfan Mohd Sufian
Haziq Zahiruddin
Wan Fatein Nabeila Wan Omar
Hazulin Mohd Radzuan
Nurul Amirah Mustapa
Wei Xin Gan
Nur Munirah Mat Salleh
Muhammad Harith Rosdi
Mohd Zulkifli Mohamad Zahir
Mohamad Suhaizi Suhaimi
Nazira Zubir
Hanifah Eydel
Nur Fazlen Zainul Abidin

Abstract

Background: Sarcopenia is an increasing concern among ageing populations as it contributes to frailty, falls, and reduced quality of life. Early screening is critical to prevent this disorder. The SARC-F questionnaire is known as a simple tool that can be used to screen for sarcopenia. It has been translated and validated in multiple languages. However, no validated Malay version currently exists, creating a critical gap for sarcopenia screening among Malay-speaking adults who primarily communicate in the Malay language. This study aimed to translate and culturally adapt the SARC-F questionnaire into a Malay version and to validate it preliminarily.


Methods: The questionnaire was subjected to forward–backward translation, followed by expert panel evaluation (n = 8). Face validity was carried out among 25 Malay-speaking community-dwelling adults to assess the clarity and comprehensibility of the Malay SARC-F questionnaire using the Face Validity Index (FVI). Reliability was assessed using internal consistency (Cronbach’s α) and test–retest reliability (Intraclass Correlation Coefficient, ICC).


Results: A translated Malay SARC-F was agreed after the forward translation. The backward translation of the Malay SARC-F showed minimal discrepancy from the original version. Expert panels agreed to revise certain phrases and terms to better suit the Malaysian context to optimise clarity and comprehension. Face validity was also excellent (I-FVI = 1.00; S-FVI = 1.00). Internal consistency was acceptable (Cronbach’s α = 0.78), and test–retest reliability was excellent (ICC = 0.88; 95% CI: 0.83, 0.92).


Conclusion: The Malay SARC-F demonstrates preliminary evidence of reliability as a culturally appropriate screening instrument for sarcopenia among Malaysian adults. Although this study establishes its preliminary psychometric soundness, larger studies are warranted to confirm construct and criterion validity.

Article Details

How to Cite
1.
Mohd Aris MAH, Mohd Sufian MSI, Zahiruddin H, Wan Omar WFN, Mohd Radzuan H, Mustapa NA, et al. Malay Language Translation, Cultural Adaptation and Pilot Testing of the SARC-F Questionnaire for Screening Sarcopenia Among the Malaysian Population. Malays J Med Sci [Internet]. 2026 Jun. 30 [cited 2026 Jul. 25];33(3):131–142. Available from: http://ejournal.usm.my/mjms/article/view/mjms_vol33-no3-2026_11
Section
Original Articles

References

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169

Papadopoulou SK. Sarcopenia: a contemporary health problem among older adult populations. Nutrients. 2020;12(5):1293. https://doi.org/10.3390/nu12051293

Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X. Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open. 2018;8(11):e021252. https://doi.org/10.1136/bmjopen-2017-021252

Chen LK, Hsiao FY, Akishita M, Assantachai P, Lee WJ, Lim WS, et al. A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 consensus update. Nat Aging. 2025;5:2164–2175. https://doi.org/10.1038/s43587-025-01004-y

Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86–99. https://doi.org/10.1002/jcsm.12783

Ranee R, Shahar S, Yee XY, Singh DKA, Mohamed Sakian NI. Prevalence and risk factors of sarcopenia among community dwelling older adults in Klang Valley. Malays J Med Health Sci. 2022;18(1):177–186.

Institute of Public Health, National Institutes of Health, Malaysia Ministry of Health. National Health and Morbidity Survey 2019: NCDs - Non-Communicable Diseases: Risk Factors and other Health Problems [Internet]. Bandar Setia Alam, Shah Alam, Selangor: Institute of Public Health; 2019 [Retrieved 2025 Oct 15]. Available at: http://www.iku.gov.my/images/IKU/Document/REPORT/NHMS2019/Report_NHMS2019-NCD_v2.pdf

Chen LK, Hsiao FY, Akishita M, Assantachai P, Lee WJ, Lim WS, et al. A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update. Nat Aging. 2025;5:2164–2175. https://doi.org/10.1038/s43587-025-01004-y

Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136–1141. https://doi.org/10.1016/j.jamda.2016.08.004

Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014;14(Suppl 1):93–101. https://doi.org/10.1111/ggi.12197

Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531–532. https://doi.org/10.1016/j.jamda.2013.05.018

Rossi AP, Micciolo R, Rubele S, Fantin F, Caliari C, Zoico E, et al. Assessing the risk of sarcopenia in the elderly: the Mini Sarcopenia Risk Assessment (MSRA) questionnaire. J Nutr Health Aging. 2017;21(6):743–749. https://doi.org/10.1007/s12603-017-0921-4

Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. https://doi.org/10.1002/jcsm.12048

Ida S, Kaneko R, Murata K. SARC-F for screening of sarcopenia among older adults: a meta-analysis of screening test accuracy. J Am Med Dir Assoc. 2018;19(8):685–689. https://doi.org/10.1016/j.jamda.2018.04.001

Barreto de Lima A, dos Santos Ribeiro G, Henriques-Neto D, Rúbio Gouveia É, Baptista F. Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil. Sci Rep. 2023;13:11698. https://doi.org/10.1038/s41598-023-39002-y

Lin YH, Lee KC, Tzeng YL, Lin YP, Liu WM, Lu SH. Comparison of four screening methods for sarcopenia among community-dwelling older adults: a diagnostic accuracy study. Geriatr Nurs. 2023;49:157–163. https://doi.org/10.1016/j.gerinurse.2022.12.007

Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O. Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc. 2016;17(12):1142–1146. https://doi.org/10.1016/j.jamda.2016.09.008

Guardia-Baena JM, Carcelén-Fraile MC, Hita-Contreras F, Aibar-Almazán A, Arévalo-Ruíz MA, Mesas-Aróstegui MA, et al. Reliability and clinical validity of the SARC-Global questionnaire for sarcopenia and sarcopenic obesity in Spanish older adults. Nutrients. 2025;17(7):1206. https://doi.org/10.3390/nu17071206

Sánchez-Rodríguez D, Marco E, Dávalos-Yerovi V, López-Escobar J, Messaggi-Sartor M, Barrera C, et al. Translation and validation of the Spanish version of the SARC-F questionnaire to assess sarcopenia in older people. J Nutr Health Aging. 2019;23(6):518–524. https://doi.org/10.1007/s12603-019-1204-z

Boteta-Gomes MI, Aibar-Almazán A, Hita-Contreras F, de Loureiro NEM, Brandão-Loureiro VAF. Cross-cultural adaptation and validation of the Portuguese version of the SARC-F in community-dwelling older adults. Diagnostics (Basel). 2024;14(11):1096. https://doi.org/10.3390/diagnostics14111096

Tsekoura M, Billis E, Tsepis E, Lampropoulou S, Beaudart C, Bruyere O, et al. Cross-cultural adaptation and validation of the Greek version of the SARC-F for evaluating sarcopenia in Greek older adults. J Musculoskeletal Neuronal Interact. 2020;20(4):505–512.

Bahat G, Yilmaz O, Kiliç C, Oren MM, Karan MA. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging. 2018;22(8):898–903. https://doi.org/10.1007/s12603-018-1067-8

Qian S, Zhang S, Lu M, Chen S, Liu L, Liu S, et al. The accuracy of screening tools for sarcopenia in older Chinese adults: a systematic review and meta-analysis. Front Public Health. 2024;12:1310383. https://doi.org/10.3389/fpubh.2024.1310383

Kim S, Kim M, Won CW. Validation of the Korean version of the SARC-F questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2018;19(1):40–45.e1. https://doi.org/10.1016/j.jamda.2017.07.006

Ida S, Murata K, Nakadachi D, Ishihara Y, Imataka K, Uchida A, et al. Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res. 2017;29(5):935–942. https://doi.org/10.1007/s40520-016-0668-5

Badwan HM, Hawamdeh Z, Mabrouk MI, Kamel MI, Alghwiri AA. Arabic adaptation and validation of the SARC-F questionnaire for sarcopenia screening in elderly populations: exploration of associated factors. J Aging Res. 2025;2025(1):7405872. https://doi.org/10.1155/jare/7405872

Alqahtani BA, Alenazi AM, Alshehri MM, Alhowimel AS, Alharbi BA, Alhwoaimel NA. Cross-cultural adaptation and validation of the Arabic version of the SARC-F for evaluating sarcopenia in Saudi older adults. BMC Geriatr. 2025;25:773. https://doi.org/10.1186/s12877-025-06349-y

Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94–104. https://doi.org/10.1111/j.1524-4733.2005.04054.x

Cruchinho P, López-Franco MD, Capelas ML, Almeida S, Bennett PM, da Silva MM, et al. Translation, cross-cultural adaptation, and validation of measurement instruments: a practical guideline for novice researchers. J Multidiscip Healthc. 2024;17:2701–2728. https://doi.org/10.2147/JMDH.S419714

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. https://doi.org/10.1097/00007632-200012150-00014

Yusoff MSB. ABC of content validation and content validity index calculation. Educ Med J. 2019;11(2):49–54. https://doi.org/10.21315/eimj2019.11.2.6

Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–497. https://doi.org/10.1002/nur.20147

Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–55. https://doi.org/10.5116/ijme.4dfb.8dfd

Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. https://doi.org/10.1016/j.jcm.2016.02.012